Patent application number | Description | Published |
20110243935 | Compositions and Methods for Immunotherapy - The invention relates to immunotherapeutic compounds, compositions that include such compounds, and methods of using the compounds, for example, to treat an individual having, at risk for, or previously treated for a cancer. | 10-06-2011 |
20110250171 | Compositions and Methods for Cancer Immunotherapy - The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer. | 10-13-2011 |
20140065100 | Compositions and Methods for Cancer Immunotherapy - The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer. | 03-06-2014 |
Patent application number | Description | Published |
20090036467 | ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS - A new class of alkylsulfonyl-substituted thiazolide compounds is described. These compounds show strong activity against hepatitis virus. | 02-05-2009 |
20100209505 | Controlled release pharmaceutical formulations of nitazoxanide - Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided. | 08-19-2010 |
20100292274 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS - A new class of haloalkyl heteroaryl benzamides is described. These compounds show strong activity against hepatitis viruses. | 11-18-2010 |
20100330173 | COMPOUNDS AND METHODS FOR TREATING INFLUENZA - This invention is directed to methods for treating and preventing influenza infection by inhibiting influenza virus HA maturation processes employing compounds of formula I. It is also directed to combinations for treating and preventing influenza infection comprising compounds of formula I and other agents. | 12-30-2010 |
20120108591 | ALKYLSULFINYL-SUBSTITUTED THIAZOLIDE COMPOUNDS - A new class of alkylsulfinyl thiazolides is described. These compounds show strong activity against hepatitis viruses. | 05-03-2012 |
20120108592 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES - A new class of salicylanilides is described. These compounds show strong activity against hepatitis viruses. | 05-03-2012 |
20120122939 | ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS - A new class of alkylsulfonyl-substituted thiazolide compounds is described. These compounds show strong activity against hepatitis virus. | 05-17-2012 |
20120294831 | USE OF THIAZOLIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES, CANCER AND DISEASES CAUSED BY INTRACELLULAR INFECTIONS - The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections | 11-22-2012 |
20140065215 | CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS OF NITAZOXANIDE - Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided. | 03-06-2014 |
20140341850 | HALOALKYL HETEROARYL BENZAMIDE COMPOUNDS - A new class of haloalkyl heteroaryl benzamides is described. These compounds show strong activity against hepatitis viruses. | 11-20-2014 |